Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
9%(1 trials)

Phase Distribution

Ph phase_1
2
10%
Ph not_applicable
11
55%
Ph early_phase_1
1
5%
Ph phase_3
1
5%
Ph phase_2
2
10%
Ph phase_4
3
15%

Phase Distribution

3

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution20 total trials
Early Phase 1First-in-human
1(5.0%)
Phase 1Safety & dosage
2(10.0%)
Phase 2Efficacy & side effects
2(10.0%)
Phase 3Large-scale testing
1(5.0%)
Phase 4Post-market surveillance
3(15.0%)
N/ANon-phased studies
11(55.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

20

all time

Status Distribution
Completed(11)
Terminated(2)
Other(7)

Detailed Status

Completed11
unknown7
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
20
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.0%)
Phase 12 (10.0%)
Phase 22 (10.0%)
Phase 31 (5.0%)
Phase 43 (15.0%)
N/A11 (55.0%)

Trials by Status

unknown735%
withdrawn210%
completed1155%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT05729503Phase 2

Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals

Withdrawn
NCT06936410Phase 2

Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery

Completed
NCT04144192Phase 1

Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects

Completed
NCT06380764Not Applicable

Greater Occipital Nerve Block Value in Management of Postdural Puncture Headache

Completed
NCT06143410Not Applicable

Intravenous Lidocaine to Reduce ED50 for Propofol Administered Using Target Controlled Infusion (TCI) During Gastroscopy

Unknown
NCT05688202Not Applicable

Simultaneous Versus Sequential Fractional CO2 Laser and Subcision Combination for Post-acne Atrophic Scars: A Split-face Comparative Study.

Completed
NCT05944887Not Applicable

Intravenous Lidocaine to Reduce Propofol Consumption During Gastroscopy.

Completed
NCT04647084Phase 4

Pilot Trial: Comparing Buzzy to Intradermal Lidocaine for Peripheral IV Cannulation in Adults

Withdrawn
NCT05825872Phase 4

Ultrasound-Guided Internal Superior Laryngeal Nerve Block for Double-Lumen Bronchial Tube

Unknown
NCT05329116Not Applicable

Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis

Unknown
NCT05318560Not Applicable

Efficacy of Local Anesthetic and Ozone Injection in Patients With Myofascial Pain Syndrome

Unknown
NCT05253508Not Applicable

Propagation Waves in Tactile Material Perception

Unknown
NCT05063578Not Applicable

The Minimum Effective Concentration of Lidocaine for Ultrasound-guided Axillary Block for Arterio-venous Fistula Creation Surgery

Unknown
NCT04964180Not Applicable

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Completed
NCT03806595Phase 1

A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine

Completed
NCT03755089Phase 4

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

Unknown
NCT00769392Not Applicable

Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection

Completed
NCT03794505Phase 3

Quality of Life and Pain With Infiltration or Suprascapular Nerve Block in Glenohumeral Arthirtis

Completed
NCT03634605Not Applicable

Effect of Tetracycline Pleurodesis on Prevention of Primary Spontaneous Pneumothorax Recurrence

Completed
NCT03323567Early Phase 1

A Comparison of Collagen, Lidocaine and Saline, in Trigger Points in Masseter Muscle.

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20